About PeptiDream
PeptiDream is a company based in Erimo (Japan) founded in 2006.. The company has 621 employees as of December 31, 2024. PeptiDream operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.
- Headquarter Erimo, Japan
- Employees 621 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Peptidream Inc.
-
Annual Revenue
$297.4 M (USD)62.57as on Dec 31, 2024
-
Net Profit
$95.63 M (USD)394.59as on Dec 31, 2024
-
EBITDA
$150.61 M (USD)146.03as on Dec 31, 2024
-
Latest Funding Round
-
Investors
Gates Foundation
& 1 more
-
Employee Count
621
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of PeptiDream
PeptiDream is a publicly listed company on the TSE with ticker symbol 4587 in Japan, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of PeptiDream
- Total Funding Total Funding
- Total Rounds 3
- Last Round Last Round
- First Round First Round
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2019 | Amount | Grant - PeptiDream | Valuation |
investors |
|
| Nov, 2017 | Amount | Grant - PeptiDream | Valuation |
investors |
|
| Jul, 2008 | Amount | Series A - PeptiDream | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in PeptiDream
PeptiDream has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Gates Foundation and UT-EC Japan. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Seed and Early stage VC firm investing in Japan
|
Founded Year | Domain | Location | |
|
Charitable foundation investments on poverty reduction and healthcare
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by PeptiDream
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - PeptiDream
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Peptidream Comparisons
Competitors of PeptiDream
PeptiDream operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Small molecules are developed for cancer and skin disease treatments.
|
|
| domain | founded_year | HQ Location |
Cancer therapies are developed using selective pathway inhibitors.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Peptidream
Frequently Asked Questions about PeptiDream
When was PeptiDream founded?
PeptiDream was founded in 2006 and raised its 1st funding round 2 years after it was founded.
Where is PeptiDream located?
PeptiDream is headquartered in Erimo, Japan. It is registered at Erimo, Hokkaido, Japan.
How many employees does PeptiDream have?
As of Dec 31, 2024, the latest employee count at PeptiDream is 621.
What is the annual revenue of PeptiDream?
Annual revenue of PeptiDream is $297.4M as on Dec 31, 2024.
What does PeptiDream do?
PeptiDream was founded in 2006 and is headquartered in Erimo, Japan. Operations focus on the biotechnology sector, where peptide-based therapeutics are created using the proprietary PDPS (Peptide Discovery Platform System) technology. Drug development targets areas including oncology, multiple myeloma, DMD and muscle disorders, influenza, and additional indications, with efforts centered on small molecule solutions for unmet medical needs.
Who are the top competitors of PeptiDream?
PeptiDream's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.
Is PeptiDream publicly traded?
Yes, PeptiDream is publicly traded on TSE under the ticker symbol 4587.
Who are PeptiDream's investors?
PeptiDream has 2 investors. Key investors include Gates Foundation, and UT-EC Japan.
What is PeptiDream's ticker symbol?
The ticker symbol of PeptiDream is 4587 on TSE.